Martin S(2019). MLH1 deficiency leads to deregulated mitochondrial metabolism. Cell Death and Disease vol. 10, 795-795.
Shailes H, Bridge G, Foxler D, Sharp TV, Silver A, Martin SA (2017). Targeting APC loss using synthetic lethality in Colorectal Cancer. MOLECULAR CANCER THERAPEUTICS. vol. 16,
Guillotin D, Austin P, Begum R, Freitas MO, Merve A, Brend T, Short S, Marino S et al.(2017). Drug-repositioning screens identify triamterene as a selective drug for the treatment of DNA mismatch repair deficient cells. Clinical Cancer Research vol. 23, (11) 2880-2890.
Locke M, Ghazaly E, Freitas MO, Mitsinga M, Lattanzio L, Lo Nigro C, Nagano A, Wang J et al.(2016). Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1. Cell Reports vol. 16, (6) 1604-1613.
Szlosarek PW, Locke M, Ghazaly E, Lattanzio L, Lo Nigro C, Martin SA (2016). Inhibition of the polyamine synthesis pathway is synthetically lethal with loss of argininosuccinate synthase 1 in cancer. vol. 76,
Martin SA(2016). The DNA mismatch repair pathway. DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications: Second Edition,
GROSE RP, Dawkins JBN, Wang J, maniati, heward, koniali, kocher, martin et al.(2016). Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma. Cancer Research
Begum R, Martin SA(2016). Targeting Mismatch Repair defects: A novel strategy for personalized cancer treatment. DNA Repair vol. 38, 135-139.
Tookman LA, Browne AK, Connell CM, Bridge G, Ingemarsdotter CK, Dowson S, Shibata A, Lockley M et al.(2016). RAD51 and BRCA2 enhance oncolytic adenovirus type 5 activity in ovarian cancer. Molecular Cancer Research vol. 14, (1) 44-55.
Rashid S, Bridge G, Yao Z, Szabadkai G, Martin SA (2015). Targeting the mitochondria for the treatment of MLH1-deficient disease. CANCER RESEARCH. vol. 75,
Begum R, Martin SA(2015). Targeting Mismatch Repair defects: A novel strategy for personalized cancer treatment. DNA Repair
Guillotin D, Martin SA(2014). Exploiting DNA mismatch repair deficiency as a therapeutic strategy. Exp Cell Res vol. 329, (1) 110-115.
Stewart GD, O'Mahony FC, Laird A, Rashid S, Martin SA, Eory L, Lubbock ALR, Nanda J et al.(2014). Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer. Eur Urol vol. 66, (5) 956-963.
Hewish M, Fontebasso Y, Martin SA, Elliott R, Perks KL, Konde A, Bajrami I, Van Weverwijk A et al. (2014). Cancer cells deficient in DNA mismatch repair (MMR) are selectively sensitive to inhibition of the DNA dependent protein kinase (DNA-PK). CANCER RESEARCH. vol. 74,
Bridge G, Rashid S, Martin SA(2014). DNA mismatch repair and oxidative DNA damage: implications for cancer biology and treatment. Cancers (Basel) vol. 6, (3) 1597-1614.
Brierley DJ, Martin SA(2013). Oxidative stress and the DNA mismatch repair pathway. Antioxid Redox Signal vol. 18, (18) 2420-2428.
Hewish M, Martin SA, Elliott R, Cunningham D, Lord CJ, Ashworth A(2013). Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress. Br J Cancer vol. 108, (4) 983-992.
Martin SA, Hewish M, Sims D, Lord CJ, Ashworth A(2011). Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers. Cancer Res vol. 71, (5) 1836-1848.
MARTIN S(2011). Mitochondrial DNA repair. DNA Repair - On the pathways to fixing DNA damage and errors, INTECH
Martin SA, Lord CJ, Ashworth A(2010). Therapeutic targeting of the DNA mismatch repair pathway. Clin Cancer Res vol. 16, (21) 5107-5113.
Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A(2010). Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol vol. 7, (4) 197-208.
Martin SA, McCabe N, Mullarkey M, Cummins R, Burgess DJ, Nakabeppu Y, Oka S, Kay E et al.(2010). DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell vol. 17, (3) 235-248.
Martin SA, Hewish M, Lord CJ, Ashworth A(2010). Genomic instability and the selection of treatments for cancer. J Pathol vol. 220, (2) 281-289.
Martin SA, McCarthy A, Barber LJ, Burgess DJ, Parry S, Lord CJ, Ashworth A(2009). Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol Med vol. 1, (6-7) 323-337.
Mendes-Pereira AM, Martin SA, Brough R, McCarthy A, Taylor JR, Kim J-S, Waldman T, Lord CJ et al.(2009). Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol Med vol. 1, (6-7) 315-322.
Lord CJ, Martin SA, Ashworth A(2009). RNA interference screening demystified. J Clin Pathol vol. 62, (3) 195-200.
Martin SA, Ouchi T(2008). Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN. Mol Cancer Ther vol. 7, (8) 2509-2516.
Martin SA, Lord CJ, Ashworth A(2008). DNA repair deficiency as a therapeutic target in cancer. Curr Opin Genet Dev vol. 18, (1) 80-86.
Tawara H, Fujiuchi N, Sironi J, Martin S, Aglipay J, Ouchi M, Taga M, Chen P-L et al.(2008). Loss of p53-regulatory protein IFI16 induces NBS1 leading to activation of p53-mediated checkpoint by phosphorylation of p53 SER37. Front Biosci vol. 13, 240-248.
Aglipay JA, Martin SA, Tawara H, Lee SW, Ouchi T(2006). ATM activation by ionizing radiation requires BRCA1-associated BAAT1. J Biol Chem vol. 281, (14) 9710-9718.
Martin SA, Ouchi T(2005). BRCA1 phosphorylation regulates caspase-3 activation in UV-induced apoptosis. Cancer Res vol. 65, (23) 10657-10662.
Martin SA, Caplice NC, Davey GC, Powell R (2003). Identification of genes expressed in the liver of the Atlantic salmon (Salmo salar). Marine Biotechnology : An Overview of Leading Field. Editors: ColliecJouault, S, 90-94.
Martin SA, Caplice NC, Davey GC, Powell R(2002). EST-based identification of genes expressed in the liver of adult Atlantic salmon (Salmo salar). Biochem Biophys Res Commun vol. 293, (1) 578-585.
Davey GC, Caplice NC, Martin SA, Powell R(2001). A survey of genes in the Atlantic salmon (Salmo salar) as identified by expressed sequence tags. Gene vol. 263, (1-2) 121-130.